Section one: Contracting authority
one.1) Name and addresses
CELL AND GENE THERAPY CATAPULT
12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND
LONDON
SE19RT
procurement@ct.catapult.org.uk
Country
United Kingdom
NUTS code
UKI44 - Lewisham and Southwark
Companies House
10016023
Internet address(es)
Main address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses
two.1.2) Main CPV code
- 73111000 - Research laboratory services
two.1.3) Type of contract
Services
two.1.4) Short description
Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV).
Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded.
A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3".
Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
two.1.5) Estimated total value
Value excluding VAT: £180,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 71900000 - Laboratory services
- 73100000 - Research and experimental development services
- 73300000 - Design and execution of research and development
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV).
Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded.
A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3".
Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £180,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
6
This contract is subject to renewal
Yes
Description of renewals
The proposed contract will be for a period of up to 6 months, with the option to extend, subject to satisfactory performance and continued need, for three additional 6-month periods (6 months + 6 months + 6 months + 6 months). The contract length will not exceed 2 (two) years.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
10 November 2022
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
10 November 2022
Local time
12:01pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Cell and Gene Therapy Catapult
London
Country
United Kingdom